Advanced Materials | Vol.32, Issue.43 | 2020-10-01 | Pages
Catalase‐Based Therapeutics: An Antioxidant Enzyme Therapeutic for COVID‐19 (Adv. Mater. 43/2020)
In article number 2004901, Jianfeng Chen, Zhihua Gan, Zhanlong He, Yunfeng Lu, and co‐workers report an antioxidant enzyme therapeutic for COVID‐19. They demonstrate that catalase, a naturally occurring enzyme commonly used worldwide in food production and as a dietary supplement, can effectively suppress the replication of coronavirus, regulate production of cytokines, and protect lung tissues from oxidative injury.
Original Text (This is the original text for your reference.)
Catalase‐Based Therapeutics: An Antioxidant Enzyme Therapeutic for COVID‐19 (Adv. Mater. 43/2020)
In article number 2004901, Jianfeng Chen, Zhihua Gan, Zhanlong He, Yunfeng Lu, and co‐workers report an antioxidant enzyme therapeutic for COVID‐19. They demonstrate that catalase, a naturally occurring enzyme commonly used worldwide in food production and as a dietary supplement, can effectively suppress the replication of coronavirus, regulate production of cytokines, and protect lung tissues from oxidative injury.
+More
APA
MLA
Chicago
Zhang, Jianjun, Fishbein, Gregory, Chen, Jianfeng, Lu, Yunfeng, Yang, Fengmei, Wen, Jing, Li, Yanyan, Ning, Zhenbo, Wang, Fang, Jiang, Ni, Jin, Weihua, Yu, Qingsong, Liu, Zhen,Qin, Meng, Hou, Yi, Wang, Shuai, Zheng, Huiwen, Liu, Chaoyong, Cao, Zheng, Nie, Kaili, Xu, Bin, Yu, Yanting, Gan, Zhihua, He, Zhanlong, Yan, Sen, Pang, Shen, Li, Jing, Wu, Jun, Li, Heng,.Catalase‐Based Therapeutics: An Antioxidant Enzyme Therapeutic for COVID‐19 (Adv. Mater. 43/2020). 32 (43),.
Select your report category*
Reason*
New sign-in location:
Last sign-in location:
Last sign-in date: